Walgreen Sees Unusually High Options Volume (WAG)
Shares of Walgreen (NYSE:WAG) was the recipient of some unusual options trading on Tuesday. Investors bought 11,395 put options on the company, AnalystRatings.Net reports. This is an increase of approximately 211% compared to the average daily volume of 3,662 put options.
A number of analysts have recently weighed in on WAG shares. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Walgreen (NYSE:WAG) to $68.00 in a research note to investors on Tuesday. Separately, analysts at Citigroup Inc. set a $63.00 price target on shares of Walgreen (NYSE:WAG) in a research note to investors on Monday. Finally, analysts at Mizuho raised their price target on shares of Walgreen (NYSE:WAG) from $58.00 to $62.00 in a research note to investors on Wednesday, September 25th. They now have a “buy” rating on the stock. One analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $56.63.
Walgreen (NYSE:WAG) traded up 4.54% on Tuesday, hitting $56.24. 13,709,831 shares of the company’s stock traded hands. Walgreen has a 1-year low of $31.88 and a 1-year high of $56.84. The stock has a 50-day moving average of $51.25 and a 200-day moving average of $49.20. The company has a market cap of $53.147 billion and a P/E ratio of 23.53.
Walgreen (NYSE:WAG) last released its earnings data on Tuesday, October 1st. The company reported $0.73 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.72 by $0.01. The company had revenue of $17.90 billion for the quarter, compared to the consensus estimate of $17.95 billion. During the same quarter in the previous year, the company posted $0.63 earnings per share. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. Analysts expect that Walgreen will post $3.12 EPS for the current fiscal year.
Walgreen Co (NYSE:WAG), together with its subsidiaries, operates the drugstore chain in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.